Stratos Wealth Advisors LLC Has $559,000 Position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Stratos Wealth Advisors LLC raised its holdings in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 140.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,500 shares of the company’s stock after acquiring an additional 4,963 shares during the quarter. Stratos Wealth Advisors LLC owned about 0.08% of iShares U.S. Pharmaceuticals ETF worth $559,000 at the end of the most recent quarter.

Several other large investors also recently added to or reduced their stakes in the business. Welch Group LLC bought a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter worth about $285,000. Spire Wealth Management boosted its position in iShares U.S. Pharmaceuticals ETF by 24.7% during the fourth quarter. Spire Wealth Management now owns 4,568 shares of the company’s stock worth $300,000 after purchasing an additional 906 shares during the period. Union Bancaire Privee UBP SA bought a new stake in iShares U.S. Pharmaceuticals ETF during the fourth quarter worth approximately $42,000. Grimes & Company Inc. acquired a new position in iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at approximately $967,000. Finally, Janney Montgomery Scott LLC raised its position in shares of iShares U.S. Pharmaceuticals ETF by 4.1% in the fourth quarter. Janney Montgomery Scott LLC now owns 6,699 shares of the company’s stock valued at $440,000 after purchasing an additional 261 shares during the period.

iShares U.S. Pharmaceuticals ETF Trading Down 0.5 %

NYSEARCA IHE opened at $70.05 on Friday. iShares U.S. Pharmaceuticals ETF has a 1 year low of $62.67 and a 1 year high of $72.94. The company has a fifty day simple moving average of $67.35 and a 200 day simple moving average of $69.09. The company has a market cap of $707.51 million, a P/E ratio of 6.49 and a beta of 0.58.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.